Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-11-20

Clinical Trial Update: Efficacy of Treating First Episode Psychosis With Folic Acid,B12 and B6 in Addition to Antipsychotic Medication [Phase 2, Phase 3]

View source ↗

Summary

A phase 2/3 trial evaluated adding folic acid, vitamin B12, and vitamin B6 to antipsychotic treatment for first episode psychosis. The study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Antipsychotic medication (unspecified)
  • Vitamin B12 (cyanocobalamin) (cyanocobalamin)
  • Vitamin B6 (pyridoxine) (pyridoxine)
  • folic acid (folic acid)

Snippet

Sponsor: Melbourne Health | Conditions: First Episode Psychosis | Phase 2, Phase 3 | Status: COMPLETED